News | TCTAP 2022
News TCTAP
News | TCTAP 2022
Was 2021 a bad year for FFR-guided PCI?
William F. Fearon, MD says analysis of FUTURE, FLOWER-MI and FAME 3 trials show FFR-guided PCI still beneficial for select patients with multivessel CAD
News | TCTAP 2022
¡®CABG helps people live longer¡¯
Cardiac surgeon S. Christopher Malaisrie, MD says CABG improves survival for MVD and LMCAD, despite recent guideline downgrades
News | TCTAP 2022
Is CABG the best approach for multivessel, left main CAD?
Mario F.L. Gaudino, MD says PCI and CABG are complementary - not antagonistic – strategies for patients with MVD, LMCAD
News | TCTAP 2022
¡®Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy¡¯
Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones
News | TCTAP 2022
Tailored de-escalation strategy in PCI and ACS: platelet function test and genetic test guidance
At TCTAP 2022, Dominick J. Angiolillo, MD outlines de-escalation strategies with PFT, genetic tests for PCI-ACS
News | TCTAP 2022